Company intelligence / Profile preview

Guangzhou Geneseed Biotech

Guangzhou, Guangdong, China

Ownership: Private
Development stage: Other

Overview

Guangzhou Geneseed Biotech is recognized as the pioneering enterprise globally focusing on circRNA research and application.[1][3][5][7] Its platforms enable design, synthesis, and production of circRNA for use in both drug development and cell therapies. The company primarily provides comprehensive research, CRO, and CRDMO services, and supports biopharma partners in developing novel circRNA-based therapeutics.[1][3][5]

Modalities: CircRNA therapyRNA therapy
Industry: Drug Discovery Services

Partnerships

Porton Advanced Solutions (strategic collaboration for circRNA drug development, CDMO partnership)[2][5]

Beyond the preview

Go deeper on Guangzhou Geneseed Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guangzhou Geneseed Biotech.

Explore the full profile